Cargando…
Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica
Myasthenia gravis (MG) and neuromyelitis optica (NMO) are autoimmune channelopathies of the peripheral neuromuscular junction (NMJ) and central nervous system (CNS) that are mainly mediated by humoral immunity against the acetylcholine receptor (AChR) and aquaporin-4 (AQP4), respectively. The diseas...
Autores principales: | Wang, Zhen, Yan, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732908/ https://www.ncbi.nlm.nih.gov/pubmed/29312313 http://dx.doi.org/10.3389/fimmu.2017.01785 |
Ejemplares similares
-
Myasthenia Gravis during the Course of Neuromyelitis Optica
por: Etemadifar, Masoud, et al.
Publicado: (2011) -
Treatment of Myasthenia Gravis Based on Its Immunopathogenesis
por: Kim, Jee Young, et al.
Publicado: (2011) -
The Emerging Role of Microglia in Neuromyelitis Optica
por: Chen, Tingjun, et al.
Publicado: (2021) -
Inflammation and autoimmune myasthenia gravis
por: Huda, Ruksana
Publicado: (2023) -
Complement Inhibitor Therapy for Myasthenia Gravis
por: Albazli, Khaled, et al.
Publicado: (2020)